Aqua Bio Technology ASA (OSL:ABTEC) EBIT : kr2.14 Mil (TTM As of Jun. 2023)

View and export this data going back to 2008. Start your Free Trial

What is Aqua Bio Technology ASA EBIT?

Aqua Bio Technology ASA's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2023 was kr7.10 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2023 was kr2.14 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Jun. 2023 was -20.69%. Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 721.99%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Aqua Bio Technology ASA's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was 1.02%.

Aqua Bio Technology ASA EBIT Historical Data

The historical data trend for Aqua Bio Technology ASA's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aqua Bio Technology ASA EBIT Chart

Aqua Bio Technology ASA Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

EBIT

Get a 7-Day Free Trial

-38.28

-13.19

-14.95

-17.66

-16.51

Aqua Bio Technology ASA Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
EBIT	Get a 7-Day Free Trial															-8.69	-8.96	-11.56	-4.96	7.10

Competitive Comparison of Aqua Bio Technology ASA's EBIT

For the Biotechnology subindustry, Aqua Bio Technology ASA's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aqua Bio Technology ASA's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Aqua Bio Technology ASA's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Aqua Bio Technology ASA's EV-to-EBIT falls into.

Aqua Bio Technology ASA EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr2.14 Mil.

Aqua Bio Technology ASA (OSL:ABTEC) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Aqua Bio Technology ASA's annualized ROC % for the quarter that ended in Jun. 2023 is calculated as:

	ROC % (Q: Jun. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2022 )	+	Invested Capital (Q: Jun. 2023 ))	/ count )
=	-16.086 * ( 1 - 1.13% )	/	( (74.571	+	79.136)	/ 2 )
=	-15.9042282	/	76.8535
=	-20.69 %

where

	Invested Capital		(Q: Dec. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	67.203	-	4.686	-	( 1.479	-	max(0, 24.823	-	12.769	+	1.479	))
=	74.571

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	66.671	-	10.028	-	( 0.727	-	max(0, 33.623	-	11.13	+	0.727	))
=	79.136

Note: The Operating Income data used here is two times the semi-annual (Jun. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Aqua Bio Technology ASA's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2022		Q: Jun. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	14.198	/	( ( (0.265 + max(1.968, 0))	+	(1.7 + max(-1.473, 0)) )	/	2 )
=	14.198	/	( ( 2.233	+	1.7 )	/	2 )
=	14.198	/	1.9665
=	721.99 %

where Working Capital is:

	Working Capital		(Q: Dec. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1.634	+	8.305	+	0.617)	-	(4.686	+	0	+	3.902)
=	1.968

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.36	+	7.621	+	0.422)	-	(10.028	+	0	+	1.848)
=	-1.473

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Aqua Bio Technology ASA's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2023 )
	=	2.141	/	210.510
	=	1.02 %

Aqua Bio Technology ASA EBIT Related Terms

Thank you for viewing the detailed overview of Aqua Bio Technology ASA's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Aqua Bio Technology ASA (OSL:ABTEC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Aqua Bio Technology ASA (OSL:ABTEC) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

ABTO:Sweden 3FZ:Germany

Address

Thormohlensgate 55, Bergen, NOR, 5008

Website

http://www.aquabiotechnology.com

Aqua Bio Technology ASA develops, produces and markets active ingredients for the personal care industry. It creates products for personal care, healthcare, and cosmetics with the help of marine biotechnology. ABT's brands include Moana-Organic skin care and Cuvget-Arctic skin care.

Aqua Bio Technology ASA (OSL:ABTEC) Headlines

No Headlines